These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
460 related articles for article (PubMed ID: 15504933)
1. Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome. Guan Y J Am Soc Nephrol; 2004 Nov; 15(11):2801-15. PubMed ID: 15504933 [TBL] [Abstract][Full Text] [Related]
2. [PPAR family and its relationship to metabolic syndrome]. Zhang XY; Chen LH; Guan YF Sheng Li Ke Xue Jin Zhan; 2005 Jan; 36(1):6-12. PubMed ID: 15881336 [TBL] [Abstract][Full Text] [Related]
3. PPARs and the kidney in metabolic syndrome. Ruan X; Zheng F; Guan Y Am J Physiol Renal Physiol; 2008 May; 294(5):F1032-47. PubMed ID: 18234957 [TBL] [Abstract][Full Text] [Related]
4. Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome-proliferator-activated receptors. Yumuk VD Ann N Y Acad Sci; 2006 Nov; 1083():306-18. PubMed ID: 17148746 [TBL] [Abstract][Full Text] [Related]
5. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes. Blaschke F; Takata Y; Caglayan E; Law RE; Hsueh WA Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):28-40. PubMed ID: 16239592 [TBL] [Abstract][Full Text] [Related]
6. Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists. Libby P; Plutzky J Am J Cardiol; 2007 Feb; 99(4A):27B-40B. PubMed ID: 17307056 [TBL] [Abstract][Full Text] [Related]
8. PPAR agonists and the metabolic syndrome. Staels B Therapie; 2007; 62(4):319-26. PubMed ID: 17983557 [TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. Brown JD; Plutzky J Circulation; 2007 Jan; 115(4):518-33. PubMed ID: 17261671 [TBL] [Abstract][Full Text] [Related]
10. The roles of peroxisome proliferator-activated receptors in the metabolic syndrome. Mansour M Prog Mol Biol Transl Sci; 2014; 121():217-66. PubMed ID: 24373239 [TBL] [Abstract][Full Text] [Related]
11. Regulatory role of peroxisome proliferator-activated receptor delta (PPAR delta) in muscle metabolism. A new target for metabolic syndrome treatment? Grimaldi PA Biochimie; 2005 Jan; 87(1):5-8. PubMed ID: 15733729 [TBL] [Abstract][Full Text] [Related]
12. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice. Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870 [TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism. Giaginis C; Tsantili-Kakoulidou A; Theocharis S Fundam Clin Pharmacol; 2007 Jun; 21(3):231-44. PubMed ID: 17521292 [TBL] [Abstract][Full Text] [Related]
15. PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome. Fiévet C; Fruchart JC; Staels B Curr Opin Pharmacol; 2006 Dec; 6(6):606-14. PubMed ID: 16973418 [TBL] [Abstract][Full Text] [Related]
16. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors. Gervois P; Fruchart JC; Staels B Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):145-56. PubMed ID: 17237841 [TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance. Guo L; Tabrizchi R Pharmacol Ther; 2006 Jul; 111(1):145-73. PubMed ID: 16305809 [TBL] [Abstract][Full Text] [Related]
18. PPAR agonists: multimodal drugs for the treatment of type-2 diabetes. Gross B; Staels B Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):687-710. PubMed ID: 18054742 [TBL] [Abstract][Full Text] [Related]
19. PPARs as targets for the modulation of cardiovascular risk factors associated with the metabolic syndrome. Fernandez AZ Curr Opin Investig Drugs; 2004 Sep; 5(9):936-40. PubMed ID: 15503647 [TBL] [Abstract][Full Text] [Related]
20. PPARs and their metabolic modulation: new mechanisms for transcriptional regulation? Ahmed W; Ziouzenkova O; Brown J; Devchand P; Francis S; Kadakia M; Kanda T; Orasanu G; Sharlach M; Zandbergen F; Plutzky J J Intern Med; 2007 Aug; 262(2):184-98. PubMed ID: 17645586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]